HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yoshihiro Tominaga Selected Research

Parathyroidectomy

7/2015A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD Study.
7/2012[Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
6/2011Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism.
4/2011[Morphological analysis of bone dynamics and metabolic bone disease. A case report of recurrent renal hyperparathyroidism].
11/2010Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism.
6/2010Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients.
5/2010[Secondary osteoporosis UPDATE. Primary hyperparathyroidism].
10/2009Restored cardiac conditions and left ventricular function after parathyroidectomy in a hemodialysis patient. Parathyroidectomy improves cardiac fatty acid metabolism assessed by 123I-BMIPP.
4/2009[Chronic kidney disease (CKD) and bone. The clinical perspective of parathyroid interventional therapy for advanced secondary hyperparathyroidism in the era of cinacalcet HCl].
3/2009[Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism due to chronic kidney disease].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yoshihiro Tominaga Research Topics

Disease

22Secondary Hyperparathyroidism
07/2015 - 06/2003
14Hyperparathyroidism
11/2013 - 03/2002
7Hyperplasia
06/2011 - 06/2003
6Kidney Diseases (Kidney Disease)
06/2015 - 05/2004
4Hypercalcemia (Milk Alkali Syndrome)
06/2015 - 02/2005
4Bone Diseases (Bone Disease)
04/2013 - 03/2003
3Hypocalcemia
11/2013 - 10/2003
3Hyperphosphatemia
04/2013 - 02/2005
3Primary Hyperparathyroidism
06/2011 - 10/2003
3Bone Resorption
06/2007 - 03/2003
2Hypophosphatemia
11/2013 - 10/2003
2Paralysis (Palsy)
10/2008 - 01/2008
2Adenoma (Adenomas)
08/2008 - 10/2003
2Neoplasms (Cancer)
05/2008 - 12/2002
2Chronic Kidney Failure (Chronic Renal Failure)
02/2006 - 10/2003
1Hemorrhage
04/2012
1Cysts
04/2012
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
04/2012
1Infection
04/2012
1Autosomal Dominant Polycystic Kidney (ADPKD)
04/2012
1Renal Cell Carcinoma (Grawitz Tumor)
04/2011
1Nephrolithiasis
05/2010
1Cicatrix (Scar)
10/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2008
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2006
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2006
1Calciphylaxis
05/2005
1Diabetes Mellitus
11/2003
1Parathyroid Neoplasms (Parathyroid Neoplasm)
10/2003
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2003
1Pain (Aches)
10/2003
1Multiple Endocrine Neoplasia Type 1 (MEN I)
10/2003
1Renal Osteodystrophy (Renal Rickets)
03/2003
1Cardiovascular Diseases (Cardiovascular Disease)
12/2002
1Osteitis
12/2002
1Calcinosis
12/2002
1Uremia
10/2002

Drug/Important Bio-Agent (IBA)

10Parathyroid Hormone (Parathormone)IBA
07/2015 - 10/2003
4Calcitriol (Calcijex)FDA LinkGeneric
06/2015 - 01/2004
4cinacalcet (Sensipar)FDA Link
07/2012 - 04/2009
4Ethanol (Ethyl Alcohol)IBA
04/2009 - 06/2003
3maxacalcitolIBA
06/2015 - 04/2006
3PhosphorusIBA
11/2013 - 09/2004
3Cyclin D1IBA
06/2011 - 10/2003
2Tacrolimus (Prograf)FDA LinkGeneric
11/2013 - 11/2003
2Vitamin DFDA LinkGeneric
07/2012 - 06/2006
1paricalcitol (Zemplar)FDA Link
06/2015
1Calcitriol Receptors (Calcitriol Receptor)IBA
06/2015
1lanthanum carbonate (Fosrenol)FDA Link
04/2013
1CalciumIBA
04/2013
1Polycystic liver diseaseIBA
04/2012
1tranilast (N 5')IBA
04/2012
1Protein Kinases (Protein Kinase)IBA
06/2011
1Interleukin-2 (IL2)IBA
04/2011
1CosmeticsIBA
10/2008
1Staphylococcal Protein A (A, Protein)IBA
02/2008
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
02/2008
1Transcription Factors (Transcription Factor)IBA
02/2008
1CCAAT-Enhancer-Binding Protein-betaIBA
02/2008
1Messenger RNA (mRNA)IBA
02/2008
1Transforming Growth Factor alpha (TGF-alpha)IBA
02/2008
1Cyclic AMP-Dependent Protein Kinase Type IIBA
02/2006
1Lipoproteins (Lipoprotein)IBA
02/2006
1fibroblast growth factor 23IBA
09/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2003
1Glucose (Dextrose)FDA LinkGeneric
11/2003
1tartrate-resistant acid phosphatase (TSAP)IBA
03/2003
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
12/2002

Therapy/Procedure

33Parathyroidectomy
07/2015 - 03/2002
9Renal Dialysis (Hemodialysis)
06/2015 - 10/2003
4Kidney Transplantation
11/2013 - 11/2003
2Transplants (Transplant)
04/2012 - 11/2003
1Nephrectomy
04/2011
1Splenectomy
10/2008
1General Anesthesia
10/2008
1Blood Component Removal (Apheresis)
02/2006
1Amputation
05/2005
1Transplantation (Transplant Recipients)
11/2003